Patent US4035374A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4035374A Expired / Lapsed US ⏱️ 0.0 years remaining

Imidazolyl alkylaminopyridone and pyridinethione compounds

Assignee: Smith Kline & French Laboratories Ltd
•
Filing: 1975-10-06
•
Granted: 1977-07-12
•
Expires: 1995-10-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Heterocyclic compounds which are inhibitors of histamine activity, in particular, inhibitors of H-2 histamine receptors. A specific compound of this invention is 2-[2-(4-methyl-5-imidazolylmethylthio)ethylamino]-4-pyrimidone.

Inventors

  • 👤 Graham John Durant
  • 👤 John Colin Emmett
  • 👤 Charon Robin Ganellin

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 19:41
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/54; C07D233/66; C07D233/86; C07D233/88; C07D239/00; C07D239/02; C07D239/24; C07D239/28; C07D239/46; C07D239/56

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 111 words
A compound 2-amino-4-or 6-pyridone or pyridinethione of the formula: ##STR4## wherein A taken together with the nitrogen and carbon atom shown forms a pyridine ring, said ring having a keto or thione group and optionally substituted by one or two lower alkyl, phenyl or benzyl groups, provided that if two of the optional substituents are present at least one is lower alkyl; R is a grouping of the formula: Het--CH.sub.2 Z(CH.sub.2).sub.n -- wherein Het is an imidazole ring, said ring being optionally substituted by lower alkyl, amino, hydroxy or halogen; Z is sulphur or a methylene group and n is 2 or 3 or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 111 words
A compound 2-amino-4-or 6-pyridone or pyridinethione of the formula: ##STR4## wherein A taken together with the nitrogen and carbon atom shown forms a pyridine ring, said ring having a keto or thione group and optionally substituted by one or two lower alkyl, phenyl or benzyl groups, provided that if two of the optional substituents are present at least one is lower alkyl; R is a grouping of the formula: Het--CH.sub.2 Z(CH.sub.2).sub.n -- wherein Het is an imidazole ring, said ring being optionally substituted by lower alkyl, amino, hydroxy or halogen; Z is sulphur or a methylene group and n is 2 or 3 or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 15 words
A compound of claim 1 wherein Het is an imidazole ring, optionally substituted by methyl.
Claim 4
Dependent Claim 9 words
A compound of claim 1 wherein n is 2.
Claim 5
Dependent Claim 9 words
A compound of claim 1, said compound being 2-[2-(4-methyl-5-imidazolylmethylthio)ethylamino]-(1H)-pyrid-4-one.
Claim 6
Dependent Claim 64 words
A compound of claim 1 of the following formula: ##STR5## wherein R has the same significance as in claim 1; X is oxygen or sulphur; Y 1 and Y 2 , which may be the same or different, are hydrogen, lower alkyl, phenyl or benzyl, provided that if Y 1 and Y 2 are both other than hydrogen, at least one is lower alkyl.

References Cited (Backward Citations)

US3654291A Cited
US3853897A Cited
US3894151A Cited
US3898335A Cited
US3923809A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-07-11 1981-01-10 1981-07-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-07-11 1985-01-10 1985-07-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-07-11 1989-01-10 1989-07-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag